• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 3
  • 2
  • Tagged with
  • 8
  • 6
  • 5
  • 5
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
1

Carotid intima-media thickness- A surrogate marker for coronary artery disease in the South African black population?

Holland, Zaiboonnisa 14 November 2006 (has links)
Faculty of Health Sciences School of Clinical Medicine 0420355x Zaiboon@hotmail.com / B-mode ultrasound measurement of the carotid intima-media thickness (CIMT) has been convincingly shown to be a predictor of coronary artery disease (CAD) in several studies. To my knowledge such assessments have not been carried out in the Black South African population, which hitherto had a low prevalence of CAD. However, with the increases in prevalence of a cluster of risk factors categorised as the Metabolic Syndrome (MS), CAD is inevitably on the increase. The purpose of this study was to evaluate the role of CIMT in predicting CAD in Black South Africans, and to correlate CIMT with the known risk factors for CAD, including those of the MS. My study has shown that CIMT predicts the extent of CAD as found at coronary angiography. Multiple regression analysis identified hypertension and fasting glucose as the most important determinants of CIMT. Age, obesity, smoking and LDL-Cholesterol also correlated positively with CIMT. The results suggest that in this population, hypertension and diabetes are crucial in the pathogenesis of thickening of the intima-media of carotid arteries, a surrogate marker of coronary artery disease.
2

Efeitos arteriais da ativação de células T, monócitos e da imunidade ao Citomegalovírus (CMV) em crianças e adolescentes com infecção pelo Vírus da Imunodeficiência Humana (HIV) / Arterial effects of T cell, monocyte and cytomegalovirus (CMV) immune activation in children and adolescents with Human Immunodeficiency Virus (HIV) infection

Sturzbecher, Fernanda Tomé 30 August 2018 (has links)
A infecção pelo Vírus da Imunodeficiência Humana (HIV) pode predispor à presença de fatores de risco cardiovascular e promover a ativação do sistema imunológico, contribuindo para a formação de lesões ateroscleróticas. A existência de coinfecções, como pelo Citomegalovírus (CMV) e a ativação imunológica inespecífica poderiam intensificar o processo de inflamação crônica e acelerar os danos vasculares decorrentes desta. O objetivo principal deste estudo foi avaliar se a recorrência da infecção pelo CMV, a magnitude da resposta imunológica específica ao CMV ou da ativação inespecífica de células T e monócitos associava-se ao aumento da espessura das camadas média e íntima das carótidas (cIMT) em crianças e adolescentes coinfectados pelo HIV e CMV. Consistiu-se de um estudo longitudinal, em que 40 crianças e adolescentes coinfectados pelo HIV e CMV foram acompanhados por 2 anos. Periodicamente avaliou-se a presença de recorrência do CMV, com o uso de detecção de DNA do CMV no soro por meio da técnica de Reação em Cadeia da Polimerase; a ativação imunológica perante este vírus com o ensaio do Quantiferon CMVR, a dosagem de anticorpos IgM e IgG contra o CMV. Também, nós medimos a ativação imunológica inespecífica de células T usando a dosagem do receptor I de TNF solúvel (sTNFRI) e a quantificação da presença HLADR+CD38+TCD8+; e a de monócitos por meio da dosagem de CD14 solúvel (sCD14). Para caracterizar adicionalmente as crianças estudadas, outros parâmetros foram registrados periodicamente: 1-Relativos à infecção pelo HIV: parâmetros clínicos e quantificação de linfócitos CD4+/CD8+ e de RNA-HIV; 2-Parâmetros antropométricos: Peso, estatura, circunferência abdominal e Índice de Massa Corporal (IMC); 3-Parâmetros Laboratoriais: lipoproteínas, glicemia, insulinemia, hemoglobina glicosilada e cálculo do índice HOMA IR. Devido à baixa incidência de recorrência da infeção pelo CMV (0,97/100 pessoas-mês) não foi possível analisar este fator no presente estudo. De maneira geral, na entrada do estudo aespessura da íntima/média das artérias carótidas da maioria (70%) dos adolescentes situava- se acima do Percentil 75 da distribuição de referência, sendo que durante o período de 2 anos não ocorreu incremento significativo da medida desse parâmetro arterial. Não foi identificada associação entre a magnitude da ativação da imunidade específica ao CMV e a evolução da cIMT ao longo de dois anos. Apesar de ter sido detectado que pequenos incrementos nos indicadores de ativação imunológica inespecífica (TNRFI, sCD14 e/ou HLADR+CD38+) associaram-se a discretas reduções da cIMT ao final de dois anos, a ativação imunológica de células T e monócitos não se associou ao incremento da espessura da íntima/média arterial durante esse período de tempo. Embora não tenhamos confirmado a nossa hipótese, dados obtidos nesse estudo podem se tornar referencia para planejamento de estudos mais amplos e com maior período de observação. / Human Immunodeficiency Virus (HIV) infection might predispose the presence of cardiovascular risk factors and promote the activation of the immune system contributing to the formation of atherosclerotic lesions. The presence of coinfections, such as by Cytomegalovirus, and the immunological unspecific activation may intensify the process of chronic inflammation and accelerate the vascular damage resulting from it. The main objective of this study was to evaluate whether the recurrence of CMV infection and the degree of the CMV-specific cellular immune response or the unspecific activation of T cells and monocytes were associated with the increase in the thickness of the carotid intima-media thickness (cIMT) in HIV/CMV-coinfected children and adolescents. A longitudinal study was carried out in which 40 HIV/CMV-coinfected children and adolescents were followed-up for 2 years. Periodically, it was determined the presence of CMV recurrence with the use of CMV-DNA detection in serum by Polymerase Chain Reaction; the specific immunological activation of this virus with the Quantiferon CMVR assay and the dosage of IgM and IgG antibodies against CMV. Also, we measured the nonspecific immunological activation of T cells using the soluble TNF receptor I (sTNFRI), and the presence of HLADR+CD38+TCD8+; and that of monocytes by soluble CD14 dosage (sCD14). To further characterize the studied children, other parameters were periodically evaluated: 1-HIV-related: clinical parameters and quantification of CD4+/CD8+ lymphocytes and HIV-RNA; 2-Anthropometric parameters: weight, height, abdominal circumference, and Body Mass Index (BMI); 3-Laboratory parameters: lipoproteins, fasting glucose, fasting insulinemia, glycosylated hemoglobin, and calculation of HOMA IR. Due to the low incidence of CMV recurrence (0.97/100 persons-month), it was not possible to analyze this factor in the present study. Overall, the cIMT of most (70%) adolescents were higher than the 75 percentile of the reference distribution at enrollment, and no significant increment occurred over a 2 year period. No association between the degree of CMV-specific immunity activation and the evolution of cIMT over 2 years was identified. Although it was found that small increments on the unspecific immunological activation markers (TNRFI,sCD14 and/or HLADR+CD38+) were associated with discrete reductions of the cIMT at the end of two years, the immunological activation did not associate with an increment of the carotid intima/media thickness over this time period. Even if we have not confirmed our hypothesis, the data obtained in this study can be used for planning bigger studies with a more prolonged observation period.
3

Efeitos arteriais da ativação de células T, monócitos e da imunidade ao Citomegalovírus (CMV) em crianças e adolescentes com infecção pelo Vírus da Imunodeficiência Humana (HIV) / Arterial effects of T cell, monocyte and cytomegalovirus (CMV) immune activation in children and adolescents with Human Immunodeficiency Virus (HIV) infection

Fernanda Tomé Sturzbecher 30 August 2018 (has links)
A infecção pelo Vírus da Imunodeficiência Humana (HIV) pode predispor à presença de fatores de risco cardiovascular e promover a ativação do sistema imunológico, contribuindo para a formação de lesões ateroscleróticas. A existência de coinfecções, como pelo Citomegalovírus (CMV) e a ativação imunológica inespecífica poderiam intensificar o processo de inflamação crônica e acelerar os danos vasculares decorrentes desta. O objetivo principal deste estudo foi avaliar se a recorrência da infecção pelo CMV, a magnitude da resposta imunológica específica ao CMV ou da ativação inespecífica de células T e monócitos associava-se ao aumento da espessura das camadas média e íntima das carótidas (cIMT) em crianças e adolescentes coinfectados pelo HIV e CMV. Consistiu-se de um estudo longitudinal, em que 40 crianças e adolescentes coinfectados pelo HIV e CMV foram acompanhados por 2 anos. Periodicamente avaliou-se a presença de recorrência do CMV, com o uso de detecção de DNA do CMV no soro por meio da técnica de Reação em Cadeia da Polimerase; a ativação imunológica perante este vírus com o ensaio do Quantiferon CMVR, a dosagem de anticorpos IgM e IgG contra o CMV. Também, nós medimos a ativação imunológica inespecífica de células T usando a dosagem do receptor I de TNF solúvel (sTNFRI) e a quantificação da presença HLADR+CD38+TCD8+; e a de monócitos por meio da dosagem de CD14 solúvel (sCD14). Para caracterizar adicionalmente as crianças estudadas, outros parâmetros foram registrados periodicamente: 1-Relativos à infecção pelo HIV: parâmetros clínicos e quantificação de linfócitos CD4+/CD8+ e de RNA-HIV; 2-Parâmetros antropométricos: Peso, estatura, circunferência abdominal e Índice de Massa Corporal (IMC); 3-Parâmetros Laboratoriais: lipoproteínas, glicemia, insulinemia, hemoglobina glicosilada e cálculo do índice HOMA IR. Devido à baixa incidência de recorrência da infeção pelo CMV (0,97/100 pessoas-mês) não foi possível analisar este fator no presente estudo. De maneira geral, na entrada do estudo aespessura da íntima/média das artérias carótidas da maioria (70%) dos adolescentes situava- se acima do Percentil 75 da distribuição de referência, sendo que durante o período de 2 anos não ocorreu incremento significativo da medida desse parâmetro arterial. Não foi identificada associação entre a magnitude da ativação da imunidade específica ao CMV e a evolução da cIMT ao longo de dois anos. Apesar de ter sido detectado que pequenos incrementos nos indicadores de ativação imunológica inespecífica (TNRFI, sCD14 e/ou HLADR+CD38+) associaram-se a discretas reduções da cIMT ao final de dois anos, a ativação imunológica de células T e monócitos não se associou ao incremento da espessura da íntima/média arterial durante esse período de tempo. Embora não tenhamos confirmado a nossa hipótese, dados obtidos nesse estudo podem se tornar referencia para planejamento de estudos mais amplos e com maior período de observação. / Human Immunodeficiency Virus (HIV) infection might predispose the presence of cardiovascular risk factors and promote the activation of the immune system contributing to the formation of atherosclerotic lesions. The presence of coinfections, such as by Cytomegalovirus, and the immunological unspecific activation may intensify the process of chronic inflammation and accelerate the vascular damage resulting from it. The main objective of this study was to evaluate whether the recurrence of CMV infection and the degree of the CMV-specific cellular immune response or the unspecific activation of T cells and monocytes were associated with the increase in the thickness of the carotid intima-media thickness (cIMT) in HIV/CMV-coinfected children and adolescents. A longitudinal study was carried out in which 40 HIV/CMV-coinfected children and adolescents were followed-up for 2 years. Periodically, it was determined the presence of CMV recurrence with the use of CMV-DNA detection in serum by Polymerase Chain Reaction; the specific immunological activation of this virus with the Quantiferon CMVR assay and the dosage of IgM and IgG antibodies against CMV. Also, we measured the nonspecific immunological activation of T cells using the soluble TNF receptor I (sTNFRI), and the presence of HLADR+CD38+TCD8+; and that of monocytes by soluble CD14 dosage (sCD14). To further characterize the studied children, other parameters were periodically evaluated: 1-HIV-related: clinical parameters and quantification of CD4+/CD8+ lymphocytes and HIV-RNA; 2-Anthropometric parameters: weight, height, abdominal circumference, and Body Mass Index (BMI); 3-Laboratory parameters: lipoproteins, fasting glucose, fasting insulinemia, glycosylated hemoglobin, and calculation of HOMA IR. Due to the low incidence of CMV recurrence (0.97/100 persons-month), it was not possible to analyze this factor in the present study. Overall, the cIMT of most (70%) adolescents were higher than the 75 percentile of the reference distribution at enrollment, and no significant increment occurred over a 2 year period. No association between the degree of CMV-specific immunity activation and the evolution of cIMT over 2 years was identified. Although it was found that small increments on the unspecific immunological activation markers (TNRFI,sCD14 and/or HLADR+CD38+) were associated with discrete reductions of the cIMT at the end of two years, the immunological activation did not associate with an increment of the carotid intima/media thickness over this time period. Even if we have not confirmed our hypothesis, the data obtained in this study can be used for planning bigger studies with a more prolonged observation period.
4

Genetic risk factors for stroke-related quantitative traits and their associated ischaemic stroke subtypes

Paternoster, Lavinia January 2009 (has links)
Stroke is the 2nd leading cause of death in the UK and worldwide. 150,000 people have a stroke each year in the UK (ischaemic stroke being the most common) and a significant proportion of NHS resources go towards the treatment of these individuals (~£2.8 billion). Twin and family history studies have shown that having affected relatives makes you between 30 and 76% more likely to suffer a stroke, suggesting that there is a genetic component to the disease. So far, no genes have been convincingly associated with stroke. Intermediate traits may be useful tools for identifying genetic factors in complex disease. For stroke, two commonly used intermediate traits are carotid intima-media thickness (CIMT) and white matter hyperintensities (WMHs), which both show high heritabilities. These traits have both been studied widely for associations with many candidate gene polymorphisms. In this thesis I systematically reviewed the literature for all genetic association studies of these two traits. Where particular associations have been studied in large numbers I meta-analysed the available data, developing novel methods for meta-analysis of genetic association data. I found there was substantial heterogeneity and small study bias in the literature and most polymorphisms have still been studied in too small numbers to make accurate conclusions. Apolipoprotein E (APOE) ε is the only polymorphism which shows a consistent association with CIMT, even when only the largest studies are analysed (MD 8μm (95% CI 6 to 11) between E4 and E3, and E3 and E2). No polymorphism has shown a convincing association with WMHs and interestingly APOE appears unlikely to be associated with this trait. This is consistent with previous work that shows that APOE is associated with large artery but not small artery stroke. Taking this hypothesis I attempted to investigate the association of APOE comparing patients who have had a large artery stroke with those who have had a small artery stroke in the Edinburgh Stroke Study cohort. However, genotyping of this polymorphism failed and I present investigatory analyses of problems from the genotyping laboratory.
5

Cardiovascular disease, type 2 diabetes and carotid ultrasound

Robertson, Christine Mary January 2015 (has links)
Cardiovascular disease contributes significantly to global morbidity and mortality and is particularly prevalent among individuals with Type 2 diabetes, which is thought to in part be due to the association between diabetes and the metabolic syndrome. Traditional cardiovascular risk prediction scores perform well in the general population but their use in people with Type 2 diabetes is limited as they are thought to underperform in high risk groups. Indeed, the use of any risk prediction in people with Type 2 diabetes is a point of discussion among clinicians as people with diabetes are thought by some to be at immediate high risk of CVD, whereas others view them as having a degree of modifiable risk which can be addressed using risk prediction. In the general population, novel markers such as cIMT and carotid plaque, as well as other potential biomarkers of cardiovascular risk, have been explored as possible adjuncts to risk scores in the prediction of cardiovascular disease. The evidence for their use in general populations has been established, although there have been no firm conclusions with regard to recommendations for their use, which is partly due to the high degree of variability in cIMT measurement. However, the evidence for their use in people with Type 2 diabetes is sparse, despite the use of such markers as surrogate CV endpoints in clinical trials. This thesis aimed to describe the frequency, distribution and change of cIMT and carotid plaque, as well as to explore the relationship of cIMT and carotid plaque with cardiovascular risk factors, prevalent cardiovascular disease and future cardiovascular events in older people with Type 2 diabetes. The association between cIMT, carotid plaque and other novel risk markers was also explored. The analysis was performed using data from the Edinburgh Type 2 Diabetes Study (ET2DS). This study is a large, prospective cohort study of 1066 men and women with Type 2 diabetes, aged 60-75 years at recruitment, living in Edinburgh and the Lothians. cIMT and carotid plaque were measured at year 1 follow up of the study. Variables concerning cardiovascular risk factors used in this thesis were obtained from the data collection performed at baseline and year 1. A mean of 3.5 years of follow up was available for analysis and is complete for the baseline cohort as data linkage was performed. Mean values of cIMT in the ET2DS were comparable with other studies of cIMT in people with Type 2 diabetes and may indeed be higher than cIMT in the general population. Measurement of cIMT by the sonographer was comparable with computer aided measurements. Increasing cIMT was independently associated (although only modestly) with increasing age, male sex and raised systolic blood pressure. Mean cIMT was associated with prevalent vascular disease and was predictive of incident global cardiovascular events and coronary artery events (but not stroke) over and above UKPDS risk factors, although the clinical impact of this on the reclassification of vascular risk (as demonstrated by net reclassification index (NRI)) was limited. There was a high prevalence of carotid plaque, and in particular “high risk” plaque, in the ET2DS. Different measures of carotid plaque were independently associated with several cardiovascular risk factors. Carotid plaque thickness was independently associated, albeit modestly, with increasing age, male sex, duration of diabetes and hypertension, plaque score with increasing age, hypertension, smoking and low BMI, and high risk plaque with hypertension and low BMI. All measures of carotid plaque were associated with prevalent vascular disease. However, despite these associations, carotid plaque did not have any additional predictive value for incident cardiovascular events over and above UKPDS risk factors. Finally, measures of cIMT and carotid plaque in the ET2DS were associated with the biomarkers ankle brachial index (ABI) and NTproBNP. In addition these markers were significantly higher in those individuals with prevalent vascular disease, suggesting a more extensive exploration of the association of these markers in relation to cardiovascular disease in the ET2DS may be warranted. cIMT and carotid plaque are modestly associated with traditional cardiovascular risk factors and prevalent cardiovascular disease in older adults with Type 2 diabetes. cIMT has been shown to be predictive of incident events while carotid plaque was not, in people with Type 2 diabetes, over and above traditional cardiovascular risk factors, although its impact on risk reclassification may only be small. Further evidence is required from the longer follow up of the ET2DS before firm conclusions can be drawn on the usefulness of cIMT and carotid plaque as risk markers in people with Type 2 diabetes. In addition, large collaborative studies could be used to further explore the relationship of carotid plaque, and change in cIMT with incident cardiovascular events, as well as exploring the additive effect of cIMT and plaque on risk prediction.
6

Sleep Duration, Sleep Insufficiency, and Carotid Intima-Media Thickness

Dietch, Jessica R. 05 1900 (has links)
Cardiovascular disease is the leading cause of death in the United States. Chronic short sleep duration is also a significant public health problem and has been linked to several markers and outcomes of cardiovascular disease. To date, inconsistency of assessments of sleep duration and insufficiency, use of covariates, and cardiovascular disease measurement across studies limits strong conclusions about the relationship between sleep duration, sleep insufficiency, and cardiovascular disease. The current study examined the association between sleep duration, sleep insufficiency, and a marker of preclinical coronary heart disease (i.e., carotid intima-media thickness) in a community sample using a cross-sectional design. Some evidence for a relationship between sleep duration and cIMT was found, with longer sleep duration predicting higher cIMT in some segments. Additionally, the interaction between sleep duration and sleep insufficiency was significant. However, neither of these effects were significant after adjusting for age and in some cases race/ethnicity, suggesting demographics may explain this association. Actigraphy and sleep diary duration assessments demonstrated significantly different correlations with cIMT in some segments, suggesting the nature of the assessment method may impact the strength or direction of the relationship between sleep duration and cIMT. Limitations and future directions are discussed.
7

Les effets du dalcetrapib, un inhibiteur de la protéine de transfert des esters de cholestérol (CETP), sur la structure et la fonction des lipoprotéines de haute densité (HDL) dans l’étude dal-PLAQUE2

Beaudet, Marie-Lou 10 1900 (has links)
No description available.
8

Social Support as a Moderator of Racial/Ethnic Differences in Subclinical Atherosclerosis: The North Texas Heart Study

García, James J. 08 1900 (has links)
This study examined racial/ethnic differences in pre-clinical disease, social support, and tested whether social support was a moderator of racial/ethnic differences in subclinical atherosclerosis. Participants were NHWs, NHBs, and Latinos (n = 283) from the baseline and cross-sectional sample of the North Texas Heart Study. Results from unadjusted models showed no significant racial/ethnic differences for common or bifurcation intima-media thickness (cIMT). However, unadjusted models for cIMT showed a main effect for race/ethnicity F(2, 229) = 3.12, p = .046, partial η2 = .027, with Latinos demonstrating significantly greater internal cIMT compared to NHB but not NHWs. In minimally adjusted models, there was a main effect for race/ethnicity, F(2, 227) = 3.10, p = .047, partial η2 = .027, with significantly greater internal cIMT in Latinos compared to NHBs but not NHWs. In fully adjusted models, racial/ethnic differences in cIMT were attenuated. Contrary to study hypotheses, no racial/ethnic differences in social support were found and social support was not a moderator of racial/ethnic differences in subclinical disease. In the North Texas Heart Study, few racial/ethnic differences emerged, with fully adjusted risk factor models accounting for these differences.

Page generated in 0.0254 seconds